Delivery Order SPE2DB22D1017-SPE2DB24FG0HB

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $6.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract, valued at $2,661.08, has a completion date of September 10, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medication. The firm-fixed-price contract has a ceiling value of $3,518.16 and a completion date of June 13, 2024. This contract award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $3,940.92, runs through April 19, 2024 and was issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $6,962.96 and a period of performance through April 10, 2024. This delivery order award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $3,483.36 and a completion date of April 8, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract, valued at $13,086.74, is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a type of prescription medication. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00, which provides a range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication. The $1,306.26 firm fixed price contract has an ultimate completion date of August 7, 2024 and was awarded on August 6, 2024. This contract is not a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
The U.S. Defense Logistics Agency (DLA) awarded a $3,513.72 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order was placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. This IDC serves as the primary vehicle...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,866.21 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA to supply a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medication. The $3,674.53 contract has a completion date of February 13, 2024 and was awarded on February 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG0HB
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The fixed-price contract, valued at $6,503.87, has a completion date of June 28, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 and running through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 9/26/24, 9:29 AM